Common Stock, Shares, Outstanding of Rein Therapeutics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Rein Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Rein Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 25,140,092, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Rein Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 25,140,092 +3,474,151 +16% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 23,046,121 +1,421,036 +6.6% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 22,005,317 +5,162,805 +31% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 21,666,012 +16,780,500 +343% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 21,665,941 +17,124,774 +377% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 21,625,085 +17,083,918 +376% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 16,842,512 +12,301,345 +271% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 4,885,512 +344,345 +7.6% 31 Dec 2023 10-K 07 Apr 2025 2024 FY
Q3 2023 4,541,167 -86,282,430 -95% 30 Sep 2023 10-Q 13 Oct 2023 2023 Q3
Q2 2023 4,541,167 -86,282,430 -95% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 4,541,167 -86,282,430 -95% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 4,541,167 +12,500 +0.28% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 90,823,597 +251,042 +0.28% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 90,823,597 +295,683 +0.33% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 90,823,597 +613,040 +0.68% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 4,528,667 -39,275,508 -90% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 90,572,555 +50,697,708 +127% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 90,527,914 +51,266,338 +131% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 90,210,557 +62,400,199 +224% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 43,804,175 +15,993,817 +58% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 39,874,847 +12,064,489 +43% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 39,261,576 +12,547,959 +47% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 27,810,358 +12,935,323 +87% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 27,810,358 +13,061,883 +89% 31 Dec 2019 10-K 24 Mar 2021 2020 FY
Q3 2019 27,810,358 +13,072,956 +89% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 26,713,617 +11,976,215 +81% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 14,875,035 +140,652 +0.96% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 14,748,475 +24,657 +0.17% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 14,737,402 +18,615 +0.13% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 14,737,402 +14,286,465 +3168% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 14,734,383 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 14,723,818 +14,291,405 +3305% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 14,718,787 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 450,937 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q4 2016 432,413 31 Dec 2016 10-K 02 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.